Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 19.57M | € 16.43M | € 32.82M | € 19.28M | € 11.69M |
Total Assets | € 81.23M | € 79.99M | € 79.27M | € 72.52M | € 50.65M |
Total Debt | € 29.29M | € 0.00 | € 28.51M | € 25.07M | € 14.82M |
Net Debt | € 9.72M | € -16.43M | € -4.31M | € 5.79M | € 3.14M |
Total Liabilities | € 58.02M | € 59.31M | € 55.66M | € 50.43M | € 32.83M |
Stockholders Equity | € 23.20M | € 20.68M | € 23.61M | € 22.09M | € 17.82M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |